These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 30913155)

  • 1. Cannabinoid hyperemesis syndrome: An unrecognized cause of nausea and vomiting.
    Smith TN; Walsh A; Forest CP
    JAAPA; 2019 Apr; 32(4):1-5. PubMed ID: 30913155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?
    Inayat F; Virk HU; Ullah W; Hussain Q
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28052951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol for treatment of cannabinoid hyperemesis syndrome.
    Hickey JL; Witsil JC; Mycyk MB
    Am J Emerg Med; 2013 Jun; 31(6):1003.e5-6. PubMed ID: 23583118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid hyperemesis syndrome: a guide for the practising clinician.
    Bajgoric S; Samra K; Chandrapalan S; Gautam N
    BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26698198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of topical capsaicin for cannabinoid hyperemesis syndrome in the emergency department.
    Wagner S; Hoppe J; Zuckerman M; Schwarz K; McLaughlin J
    Clin Toxicol (Phila); 2020 Jun; 58(6):471-475. PubMed ID: 31482758
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute Treatment of Adolescent Cannabinoid Hyperemesis Syndrome With Haloperidol, Lorazepam, and/or Capsaicin: A Single Institution Case Series.
    Brown JM; Wilsey MJ; Dhana L; Lonsdale H
    J Psychiatr Pract; 2023 Sep; 29(5):354-358. PubMed ID: 37678364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid hyperemesis syndrome.
    Heise L
    Adv Emerg Nurs J; 2015; 37(2):95-101. PubMed ID: 25929220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol, a Novel Treatment for Cannabinoid Hyperemesis Syndrome.
    Witsil JC; Mycyk MB
    Am J Ther; 2017; 24(1):e64-e67. PubMed ID: 25393073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing and treating cannabinoid hyperemesis.
    Wilson O; Lutton S; Doherty K
    Emerg Nurse; 2015 Dec; 23(8):22-5. PubMed ID: 26638755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid Hyperemesis Syndrome in Pediatrics: An Emerging Problem.
    Dosani K; Koletic C; Alhosh R
    Pediatr Rev; 2021 Sep; 42(9):500-506. PubMed ID: 34470869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid hyperemesis syndrome.
    Galli JA; Sawaya RA; Friedenberg FK
    Curr Drug Abuse Rev; 2011 Dec; 4(4):241-9. PubMed ID: 22150623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature.
    Burillo-Putze G; Richards JR; Rodríguez-Jiménez C; Sanchez-Agüera A
    Expert Opin Pharmacother; 2022 Apr; 23(6):693-702. PubMed ID: 35311429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Cannabinoid Hyperemesis Syndrome: Focus on Capsaicin.
    Stumpf JL; Williams LD
    J Pharm Pract; 2021 Oct; 34(5):786-793. PubMed ID: 32613883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cannabinoid hyperemesis syndrome: about 6 cases].
    Bertolino J; Abdo L; Khau D; Meckenstock R; Sautereau N; Jean E; Greder-Belan A; Frances Y; Cabane J; Granel B
    Rev Med Interne; 2015 Oct; 36(10):694-7. PubMed ID: 25547957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series.
    Graham J; Barberio M; Wang GS
    Pediatrics; 2017 Dec; 140(6):. PubMed ID: 29122973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid hyperemesis syndrome: an underreported entity causing nausea and vomiting of pregnancy.
    Schmid SM; Lapaire O; Huang DJ; Jürgens FE; Güth U
    Arch Gynecol Obstet; 2011 Nov; 284(5):1095-7. PubMed ID: 21170540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department.
    Richards JR
    J Emerg Med; 2018 Mar; 54(3):354-363. PubMed ID: 29310960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BET 1: Haloperidol in cannabinoid hyperemesis syndrome.
    Dida J; Walji N
    Emerg Med J; 2018 Nov; 35(11):711-712. PubMed ID: 30337420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid Hyperemesis Syndrome: A Case Report and Literature Review.
    Beech RA; Sterrett DR; Babiuk J; Fung H
    J Oral Maxillofac Surg; 2015 Oct; 73(10):1907-10. PubMed ID: 25896565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid hyperemesis: a case series.
    Donnino MW; Cocchi MN; Miller J; Fisher J
    J Emerg Med; 2011 Apr; 40(4):e63-6. PubMed ID: 19765941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.